Skip To Main Content
Gane Ka-Shu on Muck Rack

Gane Ka-Shu

As seen in: MDPI, Biomed Central (BMC)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Gane

Contact Gane, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis (pdf) | Paperity

|
By Anil Abraham, Gane Ka-Shu
| paperity.org
BMC Medicine, May 2023 This is a preview of a remote PDF: https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-023-02751-8 Walker, John, Joy, Anil Abraham, Vos, Larissa J., Stenson, Trevor H., Mackey, John R., Jovel, Juan, Kao, Dina, Madsen, Karen L., Wong, Gane Ka-Shu. , BMC Medicine, 2023, pp. 1-15, Volume 21, Issue 1, DOI: 10.1186/s12916-023-02751-8
Open in Who Shared Issue with article?

Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis | BMC Medicine | Full Text

|
By Anil Abraham, Gane Ka-Shu
| Biomed Central (BMC)
In this prospective and longitudinal study of patients with surgically resected early-stage breast cancer, we observed alterations within the gut microbiome following treatment with chemotherapy, as well as significant weight gain and an increase in body fat. Furthermore, the perturbation of the microbiome was accompanied by the development of an inflammatory response that may link chemotherapy-dependent alterations within the gut microbiome with our reported anthropometric changes.
Open in Who Shared Issue with article?

Development of Novel siRNA Therapeutics: A Review with a Focus on Inclisiran for the Treatment of Hypercholesterolemia

|
By Oluwakemi Ebenezer, Jack Tuszynski, Gane Ka-Shu, Pietro Comoglio
| MDPI
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessReview by Oluwakemi Ebenezer 1,2, Pietro Comoglio 3, Gane Ka-Shu Wong 4,5,* and Jack A.
Open in Who Shared Issue with article?
See all 4 articles